NBIX — Neurocrine Biosciences Share News
0.000.00%
Last trade - 00:00- $13.92bn
- $13.53bn
- $2.86bn
U.S. STOCKS ON THE MOVE -Health insurers, Arista, Savara
U.S. STOCKS ON THE MOVE -Virgin Galactic, Humana, Broadcom
HC Wainwright lifts PT on Neurocrine after Soleno deal
U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO
US STOCKS-Wall St ends higher as investors parse US-Iran negotiations, threats
US STOCKS-Wall St ends higher as investors parse US-Iran negotiations, threats
Deals of the day-Mergers and acquisitions
US STOCKS-Wall St clings to gains as investors assess US-Iran negotiations, threats
Soleno jumps to over one-year high as Neurocrine strikes $2.9 bln takeover deal
Deals of the day-Mergers and acquisitions
Brief: Neurocrine Biosciences Inc If Deal Terminated Under Some Circumstances Soleno Will Pay Co Termination Fee Of $95.3 Million
Soleno jumps as Nuerocrine strikes $2.9 bln takeover deal
Brief: Neurocrine To Acquire Soleno Therapeutics, Expanding Its Endocrinology And Rare Disease Portfolio
Deals of the day-Mergers and acquisitions
Soleno jumps on report of potential $2.5 billion Nuerocrine deal
Neurocrine nears $2.5 billion deal for Soleno Therapeutics, FT reports (updated)
Neurocrine nears $2.5 billion deal for Soleno Therapeutics, FT reports
Neurocrine Biosciences meets Q4 adjusted profit estimates
Neurocrine's movement disorder treatment fails late-stage trial